BridgeBio have demonstrably advanced this course of the innovative treatment for ATTR-CM, utilizing the investigational drug. Initial patient information indicates promising benefits for patients affected from this debilitating condition. The effort highlights BridgeBio's commitment to managing unmet medical needs in the heart field. Attruby: Brid